StockNews.AI
RMD
StockNews.AI
222 days

ResMed to Report Second Quarter Fiscal 2025 Earnings on January 30, 2025

1. ResMed will announce Q2 2025 results on January 30, 2025. 2. Management will host a webcast to discuss potential forward-looking information. 3. Earnings release may affect investor sentiment and stock performance. 4. ResMed's innovative solutions target chronic disease management. 5. The company operates in over 140 countries, influencing global market trends.

4m saved
Insight
Article

FAQ

Why Neutral?

Upcoming earnings might not significantly sway stock prices based on previous results.

How important is it?

Earnings results can inform on company health, affecting investor decisions.

Why Short Term?

Earnings announcements typically impact stock prices briefly, often recovering quickly.

Related Companies

RMD
January 09, 2025 16:05 ET  | Source: ResMed Inc. SAN DIEGO, Jan. 09, 2025 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the second quarter of fiscal year 2025 on Thursday, January 30, 2025, after the New York Stock Exchange closes. Following the release, ResMed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast. Earnings webcast details: • Location:https://investor.resmed.com• Date:Thursday, January 30, 2025• Time:1:30 p.m. PST / 4:30 p.m. EST• International:London, Thursday, January 30, 2025, 9:30 p.m. GMT Sydney, Friday, January 31, 2025, 8:30 a.m. AEDT   Please note, ResMed does not use outside phone lines to access the earnings call, the call is accessible via the above webcast link only. A replay of the earnings webcast will be accessible on ResMed’s website and available approximately two hours after the webcast. In addition, a phone replay will be available approximately three hours after the webcast and will be accessible from January 30, 2025, until February 13, 2025, at: • U.S.: +1 877.660.6853• International: +1 201.612.7415• Conference ID: 13750689  About ResMedAt ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries. To learn more, visit ResMed.com and follow @ResMed.

Related News